Novel drug-delivery systems for patients with chronic rhinosinusitis

Drug Design, Development and Therapy

Volumn 6, Issue , 2012, Pages 125-132

  Albu, Silviu ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Clinical trials; Nebulized antibiotics; Paranasal sinuses; Topical therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFMENOXIME; CORTICOSTEROID; FOSFOMYCIN; LEVOFLOXACIN; NEBACETIN; PLACEBO; TOBRAMYCIN; DRUG;

CHRONIC RHINOSINUSITIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG PENETRATION; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER DISEASE; MORBIDITY; NEBULIZATION; NEBULIZER; NEPHROTOXICITY; NONHUMAN; NOSE CAVITY; OTOTOXICITY; PARANASAL SINUS; PREVALENCE; QUALITY OF LIFE; REVIEW; ANIMAL; CHRONIC DISEASE; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RHINITIS; SINUSITIS;

ADMINISTRATION, INTRANASAL; ANIMALS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; PHARMACEUTICAL PREPARATIONS; QUALITY OF LIFE; RHINITIS; SINUSITIS;

EID: 84867905982     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S25199     Document Type: Review

References (41)

1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129:S1-S32.
2. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg. 2007; 137 (Suppl 3):S1-S31.
3. Fokkens W, Lund V, Mullol J; For the European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1-136.
4. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125:S103-S115.
5. Hatipoglu U, Rubinstein I. Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm. Curr Allergy Asthma Rep. 2008; 8:154-161.
6. Harvey RJ, Schlosser RJ. Local drug delivery. Otolaryngol Clin North Am. 2009;42(5):829-845.
7. Hwang PH, Woo RJ, Fong KJ. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol. 2006;20:255-261.
8. Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg. 2008;139:137-142.
9. Möller W, Lübbers C, Münzing W, Canis M. Pulsating airflow and drug delivery to paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg. 2011;19(1):48-53.
10. Möller W, Schuschnig U, Khadem Saba G, et al. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngol Head Neck Surg. 2010;142:382-388.
11. Djupesland PG, Skretting A, Winderen M, Holand T. Breath actuated device improves delivery to target sites beyond the nasal valve. Laryngoscope. 2006;116:466-472.
12. Valentine R, Athanasiadis T, Thwin M, Singhal D, Weitzel EK, Wormald PJ. A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers. Am J Rhinol. 2008;22:390-394.
13. Möller W, Schuschnig U, Meyer G, Mentzel H, Keller M. Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airfow. Rhinology. 2008;46:213-220.
14. Möller W, Schuschnig U, Meyer G, et al. Ventilation and aerosolized drug delivery to the paranasal sinuses using pulsating airflow: a preliminary study. Rhinology. 2009;47:405-412.
15. Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology. 1989;27:17-26.
16. Saijo R, Majima Y, Hyo N, Takano H. Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study. Am J Rhinol. 2004;18:1-7.
17. Negley JE, Krause H, Pawar S, Reeves-Hoché MK. RinoFlow nasal wash and sinus system as a mechanism to deliver medications to the paranasal sinuses: results of a radiolabeled pilot study. Ear Nose Throat J. 1999;78(8):550-552, 553-554.
18. Olson D, Rasgon B, Hilsinger R. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope. 2002;112:1394-1398.
19. Wormald P-J, Cain T, Oates L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004;114:2224-2227.
20. Snidvongs K, Chaowanapanja P, Aeumjaturapat S, Chusakul S, Praweswararat P. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis? Am J Rhinol. 2008;22:483-486.
21. Chiu AG, Kennedy DW. Disadvantages of minimal techniques for surgical management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2004;12:38-42.
22. Grobler A, Weitzel EK, Buele A, et al. Preand postoperative sinus penetration of nasal irrigation. Laryngoscope. 2008;118:2078-2081.
23. Homer JJ, Raine CH. An endoscopic photographic comparison of nasal drug delivery by aqueous spray. Clin Otolaryngol Allied Sci. 1998;23:560-563.
24. Homer JJ, Maughan J, Burniston M. A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration. J Laryngol Otol. 2002;116:10-13.
25. Miller TR, Muntz HR, Gilbert ME, Orlandi RR. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope. 2004;114(2):201-204.
26. Merkus P, Ebbens FA, Muller B, Fokkens WJ. The 'best method' of topical nasal drug delivery: comparison of seven techniques. Rhinology. 2006;44:102-107.
27. Karagama YG, Lancaster JL, Karkanevatos A, O'Sullivan G. Delivery of nasal drops to the middle meatus: which is the best head position? Rhinology. 2001;39:226-229.
28. Kayarkar R, Clifton NJ, Woolford TJ. An evaluation of the best head position for instillation of steroid nose drops. Clin Otolaryngol Allied Sci. 2002;27:18-21.
29. Aggarwal R, Cardozo A, Homer JJ. The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci. 2004;29:201-205.
30. Tsikoudas A, Homer JJ. The delivery of topical nasal sprays and drops to the middle meatus: a semiquantitative analysis. Clin Otolaryngol Allied Sci. 2001;26:294-297.
31. Cannady SB, Batra PS, Citardi MJ, Lanza DC. Comparison of delivery of topical medications to the paranasal sinuses via "vertex-to-foor" position and atomizer spray after FESS. Otolaryngol Head Neck Surg. 2005;133:735-740.
32. Benninger MS, Hadley JA, Osguthorpe JD, et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004;130:5-24.
33. Beule A, Athanasiadis T, Athanasiadis E, Field J, Wormald PJ. Effcacy of different techniques of sinonasal irrigation after modifed Lothrop procedure. Am J Rhinol Allergy. 2009;23:85-90.
34. Antunes MB, Feldman MD, Cohen NA, Chiu AG. Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis. Am J Rhinol. 2007;21:423-427.
35. Kamijyo A, Matsuzaki Z, Kikushima K, et al. Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 2001;28:227-232.
36. Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002;127:558-568.
37. Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J. 2002; 81:648-652.
38. Kobayashi T, Baba S. Topical use of antibiotics for paranasal sinusitis. Rhinology Suppl. 1992;14:77-81.
39. Desrosiers M Y, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 2001;125:265-269.
40. Videler WJ, van Drunen CM, Reitsma JB, Fokkens WJ. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology. 2008;46(2):92-98.
41. Lim M, Citardi MJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol. 2008; 22(4):381-389.